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Adult haemoglobin (Hb) is made up of two  and two  subunits. Mutations that
reduce expression of the - or -globin genes lead to the conditions - or
-thalassaemia, respectively. Whilst both conditions are characterized by
anaemia of variable severity, other details of their pathophysiology are
different, in part owing to the greater stability of the  chains that is conferred
through  self-association. In contrast,  subunits interact weakly, and in the
absence of stabilizing quaternary interactions the  chain () is prone to haem
loss and denaturation. The molecular contacts that confer weak self-association
of  have not been determined previously. Here, the first structure of an 2
homodimer is reported in complex with one domain of the Hb receptor from
Staphylococcus aureus. The 2 dimer interface has a highly unusual,
approximately linear, arrangement of four His side chains within hydrogen-
bonding distance of each other. Some interactions present in the 11 dimer
interface of native Hb are preserved in the 2 dimer. However, a marked
asymmetry is observed in the 2 interface, suggesting that steric factors limit the
number of stabilizing interactions that can form simultaneously across the
interface.
1. Introduction
The major form of adult haemoglobin (HbA) is a tetramer of two 
Hb () and two  Hb () subunits (Perutz et al., 1960). Each subunit
interacts with its non-identical partner through two different inter-
faces. The 11 (and 22) interface is extremely stable (Ka = 5 
1011 M1; Valdes & Ackers, 1977b) and remains essentially
unchanged by oxygen binding. The 12 (and 21) interface
undergoes a reorganization coupled to oxygen binding involving a
15 rotation of the two  dimers.
Mutations that reduce expression of the - or -globin genes lead
to the condition - or -thalassaemia, respectively (Nathan & Gunn,
1966). Insufficiency of  or  production leads to anaemia that can
range from mild to fatal (Clegg & Weatherall, 1976). In addition to
the insufficient production of normal Hb, thalassaemia mutations
lead to a relative excess of the partner Hb chain, which has cytotoxic
effects. Free Hb chains are unstable compared with native Hb owing
to the absence of native quaternary interactions. Quaternary inter-
actions reduce chain unfolding and precipitation and reduce haem
loss (Hargrove et al., 1997), which is associated with the production of
harmful reactive species catalyzed by haem iron (Rifkind et al., 2004;
Rachmilewitz & Schrier, 2001). Notably, free globin chains undergo
self-association (Bucci et al., 1965) and differences in the self-asso-
ciation properties of  or  contribute different stabilities and
different pathologies in - or -thalassaemia.
In -thalassaemia, excess  self-associates into stable 4 tetramers
(HbH). The dimer–tetramer association is more rapid than the
monomer–dimer interaction (Philo et al., 1988), giving the appear-
ance of a monomer–tetramer reaction (Ka =4 10
16 M3; Valdes &
Ackers, 1977a, 1978). 4 tetramers exhibit noncooperative and high-
affinity O2 binding and therefore do not effectively release O2 to the
tissues. Formation of 4 achieves a 20-fold stabilization against haem
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loss compared with  monomers, and consequently HbA and 4 lose
haem from the  chains at comparable rates (Hargrove et al., 1996,
1997). Nevertheless, 4 protein slowly forms intracellular precipitates,
causing oxidative damage to the membrane cytoskeleton of circu-
lating red blood cells, which manifests as haemolytic anaemia
(Advani et al., 1992). In foetal development the foetal  chain, ,
similarly forms 4 tetramers (Hb Bart’s; Kidd et al., 2001).
Compared with ,  undergoes comparatively weak self-associa-
tion to form dimers (Ka = 5–9  10
3 M1; Valdes & Ackers, 1977a;
Windsor et al., 1992), coupled with a ~25-fold increase in haem loss
compared with HbA or 4 (Hargrove et al., 1997). As a result, 
precipitation and oxidative damage occur early in erythroid cell
development (Polliack et al., 1974). Damage to, and apoptosis of,
erythroid precursors leads to compensatory proliferation of erythroid
progenitors in the bone marrow, liver and spleen, with consequent
disruption to the structure and function of these organs (a condition
known as ineffective eythropoiesis; Rachmilewitz & Schrier, 2001).
In addition to its role in disease, globin chain self-association has
significance for the Hb assembly pathway. In normal erythropoiesis, 
is produced in a slight excess over  (Vasseur et al., 2011) and in this
way  can act as a chaperone for  by outcompeting the formation of
nonfunctional 4 (Miele et al., 2001). In turn,  is stabilized by its own
chaperone,  Hb stabilizing protein (AHSP; Kihm et al., 2002; Gell et
al., 2002). A moderately strong interaction between AHSP and
oxygenated  (Ka = 5  10
7 M1) out-competes weak 2 self-
association and prevents  precipitation, while at the same time
permitting rapid kinetics of  release to  (Mollan et al., 2012).
The structures of 4 and 4 have been determined (Borgstahl et al.,
1994a,b; Kidd et al., 2001), allowing Kidd and coworkers to identify
features at the N- and C-termini of  and  that help to explain why
these chains form tetramers but  does not. Here, we present the first
crystal structure containing an 2 dimer and identify features at the 2
dimer interface that contribute to weak dimerization. The crystals
contain  bound to the first near-iron transporter (NEAT) domain of
iron-regulated surface determinant H (IsdH) from Staphylococcus
aureus (Pilpa et al., 2006), and were obtained during investigation of
Hb capture by this bacterium.
2. Materials and methods
2.1. Protein production
Hb was purified from blood as reported previously (Gell et al.,
2002). The splitting of carbonmonoxy-liganded Hb into  and 
chains was carried out using the well established p-hydroxy-
mercuribenzoate (PMB) method (Bucci & Frontice, 1965). The
resulting PMB and PMB chains were separated over DEAE
Sepharose resin (GE Healthcare). PMB was removed from  by
overnight incubation at 4C with dithiothreitol followed by purifi-
cation on an SP Sepharose column and storage at 80C. For protein
crystallography, purified carbonmonoxy  was converted to the
oxygenated form by passing a pure stream of oxygen over a protein
solution held on ice and illuminated with a focused beam from a 50 W
halogen lamp. The oxygenated  was converted to ferric (met)  by
addition of excess potassium ferricyanide in 20 mM sodium phos-
phate pH 7.0. The reaction was monitored to completion by UV–
visible spectroscopy and  was isolated using a Sephadex G-25
column. The concentration of  was estimated from the concentration
of the associated haem group, measured at 390 nm, from unfolded
globin samples in 6 M guanidine hydrochloride (extinction coefficient
37 800 M1 cm1).
IsdHN1 (IsdH residues 86–229) from S. aureus strain TCH1516 was
cloned into pET-15b (Novagen) for expression with an N-terminal
hexa-His tag. IsdHN1 was expressed and purified as described
previously (Pilpa et al., 2006) to yield a final product with the addi-
tional N-terminal sequence MGSSHHHHHHSSGLVPRGSHM.
2.2. Crystallization
Ferric  at 5 mg ml1 (20 mM sodium phosphate pH 7.0) was
mixed with one molar equivalent of IsdHN1 prepared in the same
buffer and crystallization screening was performed by the hanging-
drop vapour-diffusion method in 96-well plates using a Mosquito
nanolitre liquid-handling robot (TTP LabTech). Protein complex
(400 nl) was mixed with commercially available crystallization
screens (The JCSG+, PACT and Classics Suites, Qiagen) in a 1:1 ratio
and was incubated at 25C. Crystals of ferric –IsdHN1 appeared
within a week in 0.2 M sodium sulfate, 0.1 M bis-tris propane, 20%
PEG 3350 pH 6.5. On further optimization, single crystals appeared
in 0.2 M sodium sulfate, 0.1 M bis-tris propane, 16% PEG 3350 pH
6.5. A single crystal was transferred into a cryoprotectant solution
consisting of 30%(v/v) glycerol in the buffer from the crystallization
condition and flash-cooled in a nitrogen stream (173C).
2.3. Data collection and processing
Data were recorded (over a ’ range of 180) to a resolution of
3.05 Å using an ADSC Quantum 315r detector on the MX2 beamline
of the Australian Synchrotron at a wavelength of 0.95370 Å using the
Blu-Ice control system (McPhillips et al., 2002). X-ray diffraction data
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
X-ray source Australian Synchrotron MX2
Wavelength (Å) 0.9537
Temperature (C) 173
Detector ADSC Quantum 315r CCD
Total rotation range () 180
Space group I41
Unit-cell parameters (Å) a = b = 115.4, c = 142.4
Resolution range (Å) 50.00–3.05 (3.13–3.05)
No. of observations 40834
No. of unique reflections 17737
Completeness (%) 99.5 (99.4)
Multiplicity 2.3 (2.2)
hI/(I)i 12.9 (2.1)
Wilson B value (Å2) 119.3
Rmerge† 0.265 (0.635)
Reflections in working set‡ 16833 (1244)
Reflections in test set 904 (61)








R.m.s.d., bond lengths (Å) 0.004
R.m.s.d., bond angles () 0.639
hBi (Å2)
IsdHN1(2), chain A 82
IsdHN1(1), chain B 249
Chain C 114
Chain D 93










i IiðhklÞ. ‡ Friedel pairs were kept
separate for scaling, but were merged by REFMAC5 during structure
refinement. § A single water molecule was placed in the distal haem pocket of each
globin chain, coordinating the haem FeIII. } Diffraction precision indicator as output
from REFMAC5.
were indexed and scaled using DENZO and SCALEPACK
(Otwinowski & Minor, 1997).
2.4. Structure solution and refinement
Molecular replacement (MR) was performed using the IsdHN1 and
 subunit (minus the haem group) of AHSP––IsdHN1 (PDB entry
3ovu, D. A. Jacques, K. Krishna Kumar, T. T. Caradoc-Davies, D. B.
Langley, J. P. Mackay, J. M. Guss & D. A. Gell, unpublished work) as
search models. An unique solution was found by Phaser (McCoy,
2007) in the tetragonal space group I41 with two molecules of IsdH
N1
and two molecules of  in the crystallographic asymmetric unit. The
structure was refined using REFMAC5 (Murshudov et al., 2011), with
manual map inspection and model building being performed in Coot
(Emsley et al., 2010). The quality of the model was regularly checked
for steric clashes, incorrect stereochemistry and rotamer outliers
using MolProbity (Chen et al., 2010). All structural figures were
produced using PyMOL (Schrödinger, http://www.pymol.org).
Refined atomic coordinates and experimental structure factors have
been deposited in the Protein Data Bank (PDB entry 3s48). Data-
collection and refinement statistics are given in Table 1.
2.5. Naming conventions
In addition to the usual convention of numbering amino-acid
residues sequentially from the N-terminus of a peptide, it is
conventional in the globin field to identify the amino-acid position
relative to the structure of sperm whale myoglobin. For example, F8
indicates a residue that is functionally equivalent to the eighth
residue in helix F of sperm whale myoglobin (the haem-ligating
proximal His). Within the HbA tetramer, interfaces between the four
subunits are designated using upper-case numerals according to
convention in the field, e.g. the 1 subunit contributes to the 11,
12 and 12 subunit interfaces. The oligomeric state of globin
assemblies is designated using subscript numerals by convention, e.g.
22 refers to a complex of two  and two  subunits (that is, the HbA
tetramer).
3. Results and discussion
3.1. Crystal structure of the a-IsdHN1 complex
The structure of –IsdHN1 was determined to a resolution of
3.05 Å and refined to an Rcryst and Rfree of 0.242 and 0.268, respec-
tively. The crystallographic asymmetric unit contains an 2 dimer,
with each  monomer bound to one molecule of IsdHN1 (Fig. 1a).
One IsdHN1 domain [IsdHN1(1)] does not make any intermolecular
crystal contacts (Fig. 1b). Disorder in this region is reflected in
substantially higher B factors (Fig. 1b and Table 1, chain B) and the
relatively high Rmerge value.
The –IsdHN1 interface is not significantly different from that
observed in a previous structure in which IsdHN1 is bound to an 
dimer (PDB entry 3szk; r.m.s.d. of 0.2 Å for 141 C atoms; Krishna
Kumar et al., 2011) and is not discussed further. The structure of the
2 dimer has not previously been observed and reveals that the 2
dimer interface is equivalent to the 11 dimer interface in HbA.
Residues at, or close to, the 2 dimer interface have previously been
identified by NMR chemical shift perturbation (Fig. 1c; Dickson et al.,
2013), confirming that the crystal structure accurately represents the
2 interaction in solution. In a recent analysis of 113 crystal structures
of protein dimers from the PDB (Chen et al., 2013), the weakest
interaction (between a bromodomain and an acetylated peptide from
histone H3) had a Ka of 1  10
3 M1 (VanDemark et al., 2007). A
number of electron-transport complexes have successfully been
crystallized; these typically display Ka in the range 10
3–106 M1 and
are notable as physiologically important ‘weak’ interactions. The Ka
of the 2 dimer interface is estimated at 5–9  10
3 M1 (Valdes &
Ackers, 1977a; Windsor et al., 1992), placing this at the weak-inter-
action end of the spectrum of crystallized protein complexes.
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Figure 1
The structure of the –IsdHN1 complex. (a) Two –IsdHN1 dimers are present in the
crystallographic asymmetric unit. (b) The crystal packing is shown. One complete
(–IsdHN1)2 complex in the centre of the figure is represented as a tube (wider
tubes and hot colours indicate higher C-atom B factors). Crystal contacts are
shown as magenta patches on the grey surface of symmetry-related molecules.
IsdHN1(1) projects into a cavity in the crystal and has substantially higher B factors.
Its nearest neighbours are other symmetry-related IsdHN1(1) subunits (also shown
in tube representation). (c) Residues close to the  dimerization interface identified
by NMR (Dickson et al., 2013) are shown in stick representation on the (2) chain.
3.2. Buried His residues at the a2 interface
A highly unusual arrangement of four buried His side chains,
His103(G10) and His122(H5) from each chain, interdigitate across
the 2 dimer interface (Fig. 2a). Optimized hydrogen-bonding
patterns were investigated using MolProbity (Chen et al., 2010),
PDB2PQR (Dolinsky et al., 2004) and WHAT IF (Vriend, 1990).
These analyses show hydrogen-bond interactions between N1 of
(2)His103 and N1 of (1)His103 and between N"2 of (1)His103
and N"2 of (2)His122, forming a novel ‘histidine-zipper’ arrange-
ment (Fig. 2b).
The N"2 atom of (2)His103(G10) is within hydrogen-bonding
distance of the  carboxylate of (1)Asp126(H9). This interaction is
predicted to raise the pKa of (2)His103(G10) such that it may be in
the cationic form at physiological pH (PROPKA; Bas et al., 2008). All
other buried His residues are expected to have low pKa (<5.6) and be
uncharged. (2)Asp126(H9) does not make favourable electrostatic
interactions and therefore the partial burial of this unpaired negative
charge may be a significant factor in destabilization of the 2 inter-
face. In HbA, Asp126(H9) accepts a hydrogen bond from
Tyr35(C1). This interaction appears to contribute significantly to 
dimer stability, as substitution of Tyr35(C1) for Phe (Hb Philly)
produces an unstable Hb (Rieder et al., 1969).
As part of our structure-validation and interface analysis we also
used the PDB_REDO server, which performs an automated iterative
re-refinement and model-rebuilding procedure (Joosten et al., 2012).
PDB_REDO re-refinement relaxed the weighting towards standard
geometry, compared with the 3s48 refinement, and included
noncrystallographic symmetry and B-factor refinement. These
differences gave a moderate improvement in R and Rfree at the
expense of a greater number of rotamer, bond-length and Rama-
chandran outliers (Table 2). None of the outliers were at the 2
interface, although a number of 2 interface side chains did undergo
positional shifts with alternative hydrogen bonding (Fig. 2c). Most
notably, the guanadinium group of (2)Arg31 was positioned within
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Figure 2
The 2 dimer interface. (a) The OMIT map electron density of the 2 dimer interface contoured at 1 (mesh), showing the four buried His side chains. The OMIT map was
calculated using the SFCHECK program from CCP4 (Winn et al., 2011). (b) Hydrogen-bonding interactions at the 2 dimer interface (PDB entry 3s48). (c) Comparison of
interfacial residues and hydrogen-bonding interactions in PDB entry 3s48 (violet) and the structure re-refined by PDB_REDO (yellow). (d) Hydrogen-bonding interactions
at the 11 interface of HbA (PDB entry 2dn3; Park et al., 2006). (e) A comparison of the hydrogen-bonding interactions at the 11-equivalent interfaces of 2, 4 and 22.
Double-headed arrows indicate hydrogen bonds where the donor/acceptor atoms could potentially be reversed, for example owing to protonation of (2)His103 under the
influence of (1)Asp126. Dashed lines indicate hydrogen bonds that appear in 3s48 or the PDB_REDO re-refinement of 3s48 but not both.
Table 2
MolProbity (Chen et al., 2010) evaluation of 3s48 and 3s48 re-refined by





Poor rotamers (goal <1%) 1 (0.21%) 47 (9.67%)
Ramachandran outliers (goal <0.05%) 1 (0.18%) 4 (0.72%)
Ramachandran favoured (goal >98%) 521 (94.04%) 513 (92.60%)
C deviations > 0.25 Å (goal 0) 0 (0.00%) 6 (1.11%)
Bad backbone bonds (goal 0%) 0/4611 (0.00%) 2/4650 (0.04%)
Bad backbone angles (goal <0.1%) 0/6301 (0.00%) 6/6351 (0.09%)
hydrogen-bonding distance of the  carbonyl of (1)Phe117, and the
imidazole groups of (1)His122, (2)His103 and (1)His103 were
rotated 20–50, which resulted in the loss of a hydrogen bond
between (1)His103 and (2)His103 that is present in the 3s48
structure (Fig. 2c). Thus, experimental uncertainty in the atomic
coordinates is compatible with several hydrogen-bonding patterns,
one of these being an extended network involving (2)His103,
(1)His103 and (2)His122 (Fig. 2b). Overall, the PDB_REDO re-
refinement did not improve the model and therefore the results were
not deposited.
A pair of buried His residues, hydrogen bonded through their N1
atoms, is found in the bacterial ammonium transporter (AmtB;
Javelle et al., 2006; Liao et al., 2013; Zheng et al., 2004), but we are not
aware of structures that have three consecutive hydrogen-bonded His
residues, as may occur in the 2 dimer. However, it has previously
been speculated that a hydrogen-bonded His-zipper motif occurs at
the dimerization face of the bacterial protein RopE (repetitive
organellar protein E) from Plasmodium chabaudi (Werner et al.,
1998).
3.3. Asymmetry of the a2 dimer
In native Hb, the largest contribution to subunit interactions, based
on structure and thermodynamic measurements, comes from hydro-
phobic contacts, with a smaller number of electrostatic interactions
(Mrabet et al., 1986; Perutz et al., 1968; Valdes & Ackers, 1977a). The
total surface area buried on formation of the 2 dimer interface is
1473 Å2, which is a reduction of 18% compared with the 11
interface in Hb. The reduction in nonpolar buried surface is only
slightly greater at 24% (Table 3). Systematic analyses show a rela-
tionship between buried surface area and affinity, but also that
dissociation constants can vary over four orders of magnitude for the
same buried surface area (Chen et al., 2013). Remarkably, the
stability of the 11 and 2 dimers differs by almost eight orders of
magnitude indicating that, in this case, buried surface area is an
extremely poor indicator of affinity. Analysis of interface packing
using the program SC from the CCP4 package (Winn et al., 2011)
indicated lower shape complementarity for the 2 dimerization
interface; however, this may reflect the low resolution of data in
addition to intrinsic properties of the interface (Lawrence & Colman,
1993).
The arrangement of the two  chains deviates notably from the C2
point-group symmetry that is expected for a homodimeric complex:
the atoms in one subunit deviate on average by 2 Å from the
position expected in a truly symmetrical dimer. By comparison the
11-equivalent dimers in 4 and 4 are highly symmetric. At the
native 11 interface, the G helices of the two chains are in close
proximity across the dimer axis, raising the possibility that steric
clashes could potentially occur in this region in a homodimeric
complex. There is evidence of this in the 4 structures, where the side
chains of Cys112(G14) adopt two different rotamers to avoid
clashing (Borgstahl et al., 1994a,b). In , residues at positions G10,
G13 and G14 are larger side chains (His, Leu and Val) than their
counterparts in  (Asn, Val and Cys), potentially introducing steric
clashes that prevent symmetrical packing of the  monomers. It has
been shown that substitution of His103(G10) with the more bulky
Tyr destabilizes the native dimer interface (Hoyer et al., 2002), indi-
cating that the side chain at G10 does not reorient to relieve the steric
clash. Overall, symmetric homodimers have been postulated to be
more stable (Blundell & Srinivasan, 1996).
A comparison of hydrogen-bonding interactions at the 11-
equivalent interfaces of 2, 4 and HbA highlights the asymmetric
nature of the 2 contacts (Fig. 2e). The asymmetric interactions of His
side chains and unpaired negative charge on (2)Asp126(H9) have
already been discussed. In addition, bilateral interactions of
Arg(B12) with the backbone carbonyl of Phe(GH5) occur in 4 and
HbA, but only one of these interactions is present in 3s48. Disruption
of this interaction in Hb Prato, in which Arg31(B12) is replaced by
Ser, leads to an unstable Hb (Marinucci et al., 1979). The
PDB_REDO re-refinement of 3s48 permits bilateral interactions of
Arg31(B12), but disrupts symmetrical interactions of Ser35(B12).
4. Conclusion
The structure reveals the 2 dimer interface, through which  self-
associates weakly in solution. The 2 dimer interface reveals a novel
hydrogen-bonding network involving up to three of the four buried
His side chains. To our knowledge, such a ‘histidine zipper’ has not
been described previously. Marked asymmetry in the interface
contacts suggests that steric factors reduce the number of stabilizing
contacts that can be formed by  homodimers compared with 
homodimers or  heterodimers, with the consequence of reduced 
stability in -thalassaemia.
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